Revue SOAO - N° 02 - 2008, pp. 20-24
F. COULIBALY et al.
24
orientant devant un abcès cornéen résistant
aux traitements antibiotiques classiques, au
même titre qu’une kératomycose.
Le pronostic visuel nal est fonction de la
précocité d’un traitement amibien efcace.
La gravité de cette affection justifie un
traitement probabiliste anti-amibien efcace
en cas de doute diagnostic.
references
1-Illingworth CD,Cook SD.Acanthamoeba Keratititis,
Surv Ophthalmol 1998,42:493-508
2-RadfordCF,LEHMANOJ, Dart JK. Acanthamoeba
Keratitis: Multicentre Survey in England
1992-6. Br.J.Ophtahlmol 1998; 82:1387-92.
3-Bacon AS, Frazer DG, Dart JK et al. A review
of 72 consecutive cases of Acanthamoeba
Keratitis,1984-1992. Eye 1993;7:719-25.
4-Sharma S, Garg P, Rao GN. Patient characteristics,
diagnosis, and treatment of non-contact
lens related. Acanthamoeba Keratitis. BR J
O p h t h a l m o l 2 0 0 0 ; 8 4 : 1 1 0 8 .
5-Auran JD, Starr MB, Jakobiec FA. Acanthamoeba
Keratitis: a review of the literature. Cornea
1987;6;2-26.
6-Illingworth CD Cook SD, Karabatsas CH, Esaty
DL. Acanthamoeba Keratitis : risk factors and
outcome. BR J Ophtalmol 1995;79:1078-82.
7-Mathers WD, Stuphin JE, Folberg R et
al.Outbreak of Keratitis presumed to be
caused by Acanthamoeba. Am J Ophtalmol
1996;121:129-42.
8-Bacon AS, Dart JK, Fiecker LA, Matheson MM.
Acanthamoeba Keratitis.The value of the early
diagnostic. Ophtalmology.1993;100:1238-
43.
9-D’Aversa G, Stern GA, Driebe WT. Diagnosis and
successful medical treatment of Acanthamoeba
keratitis. Arch Ophtalmol 1995;1113:23.
10-Ledee DR, Hay J, Byers TJ, Seal DV,Kirkness
CM. Acanthamoeba grifni:Molecular charac-
terization of a new corneal pathogen. Invest
Ophtalmol Vis Sci 1996;37:544-50.
11-Chynn EW, Lopez MA, Pavan-Langston D,
Talamo JH. Acanthamoeba keratitis. Contact
lens and non contact lens characteristics.
Ophtalmology 1995;102:1369-73.
12-Cardine S,Bourcier T,Chaumeil C et al. Prise en
charge clinique et pronostic des kératites ami-
biennes. J Fr Ophtalmol 2002 ;25 :1007-13.
13-Schaumberg DA,Snow KK,Dana R.The
epidemic of Acanthamoeba keratitis:where do
we stand? Cornea 1998;17:3-10
14-Kumar R, Lloyd D. Recent advances in
treatement of Acanthamoeba keratitis. Clin
Infect Dis 2002;35:434-41.
15-Moore MB.Acanthamoeba keratitis.Arch
Ophtalmology 1998;106:1181-83.
16-Petit DA,Williamson J,Cabrol GA et al. In vitro
destruction of nerve cell cultures by Acan-
thamoeba spp. Parasitol 1996;82:769-77.
17-Claerhout I,Kestelyn PH.Acanthamoeba
keratitis:a review.Bull soc belge ophtalmol
1999;274:71-82.
18-Tabin G, Taylor H, Snibson G et al. Atypical
presentation of Acanthamoeba keratitis.
Cornea 2001;20:757-59.
19-Devonshire P, Munro FA,Albernethy C,Clark
BJ. Microbial contamination of contact lens
casesin the west of Scotland. Br J Ophtalmolol
1993;77:41-45.
20-Gray TB, Cursons RT, Sherwan JF, Rose
PR. Acanthamoeba, bacterial and fungal
contamination of lens storage cases. Br J
Ophtalmolol 1995;79:601-5.
21-Lehmann OJ,Green SM,Morlet N et al.
Polymerase chain reaction analysis of corneal
epithelial and tear samples in the diagnosis of
Acanthamoeba keratitis. Invest Ophtalmolol
Vis Sci 1998;39:1261-65.
22-Mathers WD,Nelson SE,Lane JL et al. Con rma- Conrma-
tion of confocal microscopy of Acanthamoeba
keratitis using polymerase chain reaction
analysis. Arch Ophtalmolol 2000;118:18-183.
23-Zamfir O, Yera H, Bourcier T, Battelier
L, Dupouy-Camet J, Tourte-Schaeffer C,
Chaumel C. Diagnostic par PCR des hératites à
acamthamoeba spécies; J Fr Ophtalmol.2006;
29, 1034-40
24-Seal D, Hay J, Kirkness C et al. Successful
medical therapy of Acanthamoeba keratitis
with topical chlorhexidine and propamidine.
Eye 1996;10:413-21.
25-Lindquist TD.Treatment of Acanthamoeba
keratitis. Cornea 1998;17:11-6.
26-Hargrave SL,McCulley JP,Husseini Z.
Results of a trial of combined propamidine
isethionate and neomycin therapy for Acan-
thamoeba keratitis.Brolene Study Group.
Ophtalomology 1999;106:952-7.
27-Radford CF,MInassian DC,Dart JK.
Acanthamoeba keratitis in England and
Wales:incidence,outcome,and risk factors. Br
J Ophtalmol 2002;86:536-542.